Series B Therapeutics Companies

ALPFA Medical develops medical devices using pulsed field ablation for prostate treatment.

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Expedition Therapeutics develops treatments for COPD and other inflammatory respiratory diseases.

Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.

Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.

Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.

Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

Ona Therapeutics develops antibody-drug conjugates and therapies for the treatment of advanced and treatment-resistant cancers.

Advanced NanoTherapies researcehes biodegradable functionalized nanoparticle technology.

Nuclidium is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.